Therapy Areas: Oncology
16 November 2018 - United States-based Merck's anti-PD-1 therapy, Keytruda (pembrolizumab), significantly improved overall survival rate in the phase three Keynote-181 oesophageal cancer trial, i...
15 November 2018 - - US-based clinical-stage immunotherapy company Harpoon Therapeutics, Inc has closed a USD 70m Series C equity financing, the company said.

OrbiMed served as the lead n...
15 November 2018 - - Anglo-Swedish pharmaceutical company AstraZeneca (OTC: AZNCF) has received positive full results from the DECLARE-TIMI 58 cardiovascular outcomes trial for Farxiga (dapagliflozin)...
15 November 2018 - - US-based biopharmaceutical company Brooklyn ImmunoTherapeutics presented the clinical results of IRX-2 therapy in resectable breast cancer and head and neck cancer that were prese...
15 November 2018 - Tikcro Technologies Ltd (OTCQB: TIKRF), a pre-clinical stage developer of antibodies for cancer immune-therapy, reported yesterday its financial results for the third quarter ended ...
15 November 2018 - The US Food and Drug Administration (FDA) has granted priority review to Switzerland-based Roche for its Tecentriq (atezolizumab) in combination with chemotherapy as the first-line ...
Related Headlines